2WQI
Crystal structure of the human p73 tetramerization domain
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-1 |
Synchrotron site | ESRF |
Beamline | ID23-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | ADSC QUANTUM 315r |
Spacegroup name | H 3 |
Unit cell lengths | 76.110, 76.110, 79.630 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 23.780 - 1.700 |
R-factor | 0.211 |
Rwork | 0.209 |
R-free | 0.25400 |
Structure solution method | MAD |
Starting model (for MR) | NONE |
RMSD bond length | 0.005 |
RMSD bond angle | 0.981 |
Refinement software | PHENIX ((PHENIX.REFINE)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.800 | 1.790 |
High resolution limit [Å] | 1.700 | 1.700 |
Rmerge | 0.060 | 0.240 |
Number of reflections | 18950 | |
<I/σ(I)> | 17.9 | 5 |
Completeness [%] | 100.0 | 100 |
Redundancy | 6.4 | 5.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.2 | 290 | SITTING DROP VAPOR DIFFUSION AT 17 DEGREE C. PROTEIN SOLUTION: 15 MG/ML IN 20 MM TRIS (PH 8.5), 50 MM NACL. CRYSTALLIZATION BUFFER: 0.1 M SODIUM CITRATE (PH 6.2), 40% PEG 600. |